Avalyn’s upsized IPO; Alector ends another study in GSK partnershipnews2026-04-30T15:33:40+00:00April 30th, 2026|Endpoints News|
Analysts focus on three programs in big year for Bristol Myersnews2026-04-30T15:33:19+00:00April 30th, 2026|Endpoints News|
XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue risenews2026-04-30T15:13:09+00:00April 30th, 2026|Endpoints News|
What we heard at a health tech conference in Bostonnews2026-04-30T14:29:09+00:00April 30th, 2026|Endpoints News|
Dopant boosts carbon nanotubes’ conductivity tenfoldnews2026-04-30T13:30:00+00:00April 30th, 2026|Chemistry World|
CVS’ healthcare delivery chief eyes potential in clinical AInews2026-04-30T13:00:27+00:00April 30th, 2026|Endpoints News|
